Alpine Global Management’s Verona Pharma VRNA Stock Holding History

Alpine Global Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,000	Closed	-$3.2M	–	429
2025 Q3	$3.2M	Buy	+30,000	New	+$3.13M	0.65%	34

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Alpine Global Management's VRNA Position: Q4 2025 in Review

Alpine Global Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 30,000 shares — an estimated $3.2M sold.

Alpine Global Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $3.2M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Alpine Global Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Alpine Global Management sold 30,000 Verona Pharma shares in Q4 2025, an estimated $3.2M.
Alpine Global Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Alpine Global Management's Verona Pharma position peaked at $3.2M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Alpine Global Management's 13F filing for Q4 2025, filed 17 Feb 2026.